Cargando…
Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs
BACKGROUND: Decisions relating to the funding of new drugs are becoming increasingly challenging due to a combination of aging populations, rapidly increasing list prices, and greater numbers of drug-indication pairs being brought to market. This is especially true in cancer, where rapid list price...
Autores principales: | Costa, Sarah, Bentley, Colene, Regier, Dean A., McTaggart-Cowan, Helen, Mitton, Craig, Burgess, Michael M., Peacock, Stuart J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647147/ https://www.ncbi.nlm.nih.gov/pubmed/31331312 http://dx.doi.org/10.1186/s12889-019-7303-2 |
Ejemplares similares
-
Trade-offs, fairness, and funding for cancer drugs: key findings from a deliberative public engagement event in British Columbia, Canada
por: Bentley, Colene, et al.
Publicado: (2018) -
Addressing the affordability of cancer drugs: using deliberative public engagement to inform health policy
por: Bentley, Colene, et al.
Publicado: (2019) -
Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups
por: Hodgetts, Katherine, et al.
Publicado: (2014) -
Sharing linked data sets for research: results from a deliberative public engagement event in British Columbia, Canada
por: Teng, Jack, et al.
Publicado: (2019) -
The ASTUTE Health study protocol: Deliberative stakeholder engagements to inform implementation approaches to healthcare disinvestment
por: Watt, Amber M, et al.
Publicado: (2012)